Proscia

What is Proscia?

Proscia is an AI platform company for digital pathology and precision medicine. Its flagship Concentriq platform manages pathology cases and images for clinical diagnostics and drug development.

Key capabilities of Proscia

• Concentriq AP-Dx: FDA-cleared for primary clinical diagnosis
• Concentriq AP: Research use only edition for anatomic pathology
• Concentriq LS: Research use only edition for life sciences
• Case management: Handles about 12 million cases annually across customers
• Collaboration: Case sharing, second opinions and remote work
• AI integration: Enterprise AI layer with interoperable third-party applications
• Workload balancing: Routes cases between sites

How Proscia works

Labs digitize slides and manage them in Concentriq, which centralizes diagnostic data and standardizes workflows across sites. Pathologists share cases and request second opinions remotely, and cases can be routed among sites to balance workload. AI applications from third parties plug into the platform's enterprise AI layer.

Who uses Proscia?

Proscia is used by 16 of the 20 top pharmaceutical companies and 4,000+ hospitals and clinics. Named customers include Bayer, Gilead, Lilly, Bristol Myers Squibb, Labcorp and Unilabs. Concentriq earned Best in KLAS 2026 for digital pathology.

Proscia pricing

Proscia does not publish pricing. Enterprise terms come from the vendor.

Proscia alternatives

Alternatives in digital pathology include Paige and Ibex Medical Analytics, which emphasize AI-assisted diagnosis. Proscia emphasizes an enterprise case management platform with an open AI layer.